| abstract |
Methods and reagents for early detection of myocardial infarction determine the level of CK-MM A and the level of the combined CK-MM A and CK-MM B in in a serum sample. From these measurements, the time of the acute phase can be more accurately determined. Novel anti-(CK-MM A ) antibodies, anti-(CK-MM B ) antibodies, anti-(CK-MM (A+B) ) antibodies, labeled and insolubilized derivatives of these antibodies, labeled MM A , and kits containing one or more of these reagents are also described. |